GenTel BioSciences, Inc. and Eprogen, Inc. Announce Partnership to Commercialize Whole Proteome Arrays

MADISON, Wis.--(BUSINESS WIRE)--Gentel® Biosciences, a protein microarray life sciences company, announces a technology partnership with Eprogen® to create products for the discovery of new autoantibody biomarkers using whole proteome microarrays.